For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

St. David's in Austin is the first in country to use new dual catheter to fix heart flutter and AFib at the same time.

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...

Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

The ablation catheter manufacturing clean room at Abbott Labs in Plymouth in 2021. Abbott recently secured approval to market its new pulse field ablation device for atrial fibrillation in Europe ...